Pancreatic cancer is notorious for being difficult to detect in its early stages due to vague symptoms that can easily be attributed to other conditions. Common symptoms include: Persistent abdominal ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

Cancer remains one of humanity’s most formidable challenges, claiming the lives of millions every year despite decades of medical progress. While some cancers respond well to treatment when diagnosed ...

The word "cancer" is scary regardless of the type, but few types of cancer are as lethal as pancreatic cancer. Based on estimates from the American Cancer Society in 2013, an estimated 45,220 people ...

Atebimetinib combined with modified chemotherapy achieved a 94% six-month overall survival rate in first-line pancreatic cancer patients, surpassing the typical 67% with standard treatment. The ...

LOS ANGELES (CNS) -- A team of researchers from the UCLA Jonsson Comprehensive Cancer Center has been awarded two research grants totaling $6 million from the National Institutes of Health to identify ...

HUTCHMED has advanced its ongoing study of surufatinib and camrelizumab for treatment‑naïve metastatic pancreatic ductal ...

More than 67,000 Americans are expected to be diagnosed with pancreatic cancer this year, but a new blood test is offering ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

A phase 3 trial found that adding chemoradiotherapy (CRT) after induction chemotherapy in patients with unresectable pancreatic cancer did not extend overall survival compared to chemotherapy alone ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Scientists developed an antibody treatment that reawakens the immune system ...

The American Cancer Society’s Report on the Status of Cancer Disparities in the United States examines disparities in cancer occurrence and outcomes, and analyzes the factors that contribute to these ...